268 related articles for article (PubMed ID: 31910825)
1. Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes.
Foligno S; De Luca D
Respir Res; 2020 Jan; 21(1):8. PubMed ID: 31910825
[TBL] [Abstract][Full Text] [Related]
2. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
[TBL] [Abstract][Full Text] [Related]
3. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.
Tridente A; De Martino L; De Luca D
Respir Res; 2019 Feb; 20(1):28. PubMed ID: 30728009
[TBL] [Abstract][Full Text] [Related]
4. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
[TBL] [Abstract][Full Text] [Related]
6. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
7. Synthetic surfactant for respiratory distress syndrome in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
[TBL] [Abstract][Full Text] [Related]
8. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; 1997(2):CD000511. PubMed ID: 10796380
[TBL] [Abstract][Full Text] [Related]
10. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
11. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates.
Sabzevari F; Eslamian M; Karami Robati F; Bahmanbijari B; Daei Parizi Z; Jamali Z
BMC Pediatr; 2023 Dec; 23(1):608. PubMed ID: 38036980
[TBL] [Abstract][Full Text] [Related]
13. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
14. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
Soll RF; Blanco F
Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
16. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.
Soll R; Ozek E
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD001079. PubMed ID: 20091513
[TBL] [Abstract][Full Text] [Related]
18. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
Pfister RH; Soll RF; Wiswell T
Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
[TBL] [Abstract][Full Text] [Related]
19. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
Soll R; Ozek E
Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
[TBL] [Abstract][Full Text] [Related]
20. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
